MGCHRI completes 150 robotic uro-oncology surgeries
Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) has reached a milestone by performing 150 complex robotic uro-oncology surgeries, doctors said on Saturday.
The hospital is also the first in Andhra Pradesh to perform Retzius-sparing robotic radical prostatectomy, an advanced minimally invasive technique for treating prostate cancer, they said.
The procedure preserves key anatomical structures that support bladder control. In selected patients, this could allow earlier recovery of urinary continence and a better quality of life after surgery.
The surgeries include 78 prostate procedures, 40 partial nephrectomies, 20 radical nephrectomies and 10 radical cystectomies. The rest were other complex procedures, including post-chemotherapy retroperitoneal lymph node dissection (RPLND).
Dr. Murali Krishna Voonna, managing director and chief surgical oncologist of MGCHRI, said the milestone reflected the institute’s commitment to making advanced super-speciality cancer care accessible in the state through specialised expertise, advanced technology and multidisciplinary care.
Dr. Rupali Basu, regional business head (East & Andhra Pradesh) of HCG Hospitals, said the achievement brought advanced cancer care closer to patients. She added that robotic surgery, combined with 3D imaging, supports organ preservation, reduces surgical trauma, and aids safer recovery.


